Deals
Walgreens Needs Rite Aid More Than Ever
The acquisition would bring an immediate sales boost and add further scale to its most important business.
This article is for subscribers only.
As Walgreens Boots Alliance tries to convince investors that its $17.2 billion acquisition of rival pharmacy company Rite Aid is on track, it may need the deal more than ever.
Walgreens beat earnings expectations for its third fiscal quarter on Wednesday, coming in at $1.18 a share compared with analysts' predictions of $1.14. The company also increased the low end of its full-year EPS guidance by 10 cents.